期刊文献+

胰岛素对高糖诱导HepG2细胞ACAT2表达的影响 被引量:1

Influence of insulin on acyltransferase-2 expression induced by high glucose in HepG2 cells
下载PDF
导出
摘要 目的探讨胰岛素对高糖诱导人肝癌组织(HepG2)细胞中酰基辅酶A:胆固醇酰基转移酶2(ACAT2)表达的影响。方法将培养好的HepG2细胞以0.7×106L-1密度接种于6孔培养板内过夜培养,加入无血清培养基继续培养24 h后分别用正常培养基(对照组)、含终浓度为25 mmol/L甘露醇溶液(甘露醇组)和25 mmol/L葡萄糖溶液(高糖组)培养基分别与细胞孵育12 h;胰岛素组用含总浓度25 mmol/L葡萄糖培养基与细胞孵育4 h后,加入终浓度为30 mU/L胰岛素再孵育8 h。采用反转录-聚合酶链反应(RT-PCR)和蛋白免疫印迹(Western blot)法检测ACAT2的表达水平。结果高糖组HepG2细胞ACAT2表达明显高于对照组(P<0.01),胰岛素组ACAT2表达显著低于高糖组(P<0.01)。结论胰岛素可下调高糖诱导的ACAT2的表达。 Objective To study the effects of insulin on acyl-CoA: cholesterol acyltransferase-2 (ACAT2) expression in- duced by high glucose in HepG2 cells. Methods Cultivated HepG2 cells with density of 0.7×10^6 L^-1 were inoculated in six well culture plates for overnight culture, and continued cultivation in serum-free medium for 24 h,then the HepG2 cells were incubat- ed for 12 h in normal culture medium (control group), 25 mmol/L mannitol solution (mannitol group) and 25 mmol/L glucose solu- tion (high glucose group ) respectively. In the insulin group, HepG2 cells were incubated by 25mmol/L glucose for 4 h, then re-in- cubated by 30 mU/I, insulin for 8 h. The expression level of ACAT2 was detected by RT-PCR and Western blot. Results The expression of ACAT2 in the high glucose group was significant higher than that in the control group(P〈0.01 ) ,the expression of A CAT2 in the insulin group was significant lower than that in the high glucose group(P〈0.01 ). Conclusion Insulin can down-regu- late the expression of ACAT2 induced by high glucose.
出处 《现代医药卫生》 2013年第12期1783-1784,1786,共3页 Journal of Modern Medicine & Health
关键词 甾醇O-酰基转移酶 酰基辅酶A 肿瘤细胞 培养的 胰岛素 高糖 Sterol O-acyhransferase Acyl coenzyme A Tumor cells,cultured Insulin High glucose
  • 相关文献

参考文献11

  • 1Sakashita N,Miyazaki A,Chang CC,et al. Acyl-coenzyme A: cholesterol acyhransferase 2 (ACAT2) is induced in monoeyte- derived macrophages:in vivo and in vitro studies[J], l.ab Invest. 2003, 83(11): 1569-1581.
  • 2张闻宇,张素华,李蓉,龚莉琳.葡萄糖对HepG2细胞酰基辅酶A:胆固醇酰基转移酶2表达的影响[J].现代医药卫生,2012,28(10):1451-1453. 被引量:2
  • 3Chang CC,Sakashita N, Ornvold K, et al. hnmunological qnanti- ration and localization of ACAT-Iand ACAT-2 in human liver and small intestine[J]. J Biol Chem, 2000,275 (36) :28083-28092.
  • 4Lee RG,Shah R ,Sawyer JK,et al. ACAT2 contributes cholesteryl esters to newly secreted VLDl,,whereas LCAT adds eholesteryl ester to LDL in mice[J]. J Lipid Res,2005,46(6) : 1205-1212.
  • 5Hori M,Satoh M,Furukawa K,et al. Acyl-coenzyme A :choles- terol acyltransferase-2 (ACAT-2) is responsible for elevated in- testinal ACAT activity in diabetic rats[J]. Arterioscler Thromb Vase Biol, 2004,24 (9) : 1689-1695.
  • 6Dullaart RP,De Vries R,Seheek L,et al. Type 2 diabetes melli- tt, s is associated with differential effects on plasma cholesterwl ester transfer protein and phospholipid transfer protein activities and eoncentrations [J]. Stand J Clin Lab Invest, 2004,64 (3) : 205-215.
  • 7Borggreve SE, De Vries R, Dullaart RP. Alterations in high-den- sity lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus : role of lipolytic enzymes,lecithin, cholesterol acy[transferase and lipid transfer proteins[J]. Eur J Clin Invest, 2003,33 (12) : 1051 -1069.
  • 8Allister EM,Pal S,Thomson AM,et al. Insulin decreases the se- cretion of apoB-100 from hepatic HepG2 cells but does not de- crease the secretion of apoB-48 from intestinal CaCo-2 cells[J]. J Biomed Sci ,2004,11 (6) :789-798.
  • 9Goldberg lJ. Clinical review 124 : Diabetic dyslipidemia : causes and consequences [J]. J Clin Endocrinol Metab,2001,86 (3) 965-971.
  • 10Borradaile NM ,de Dreu LE ,Huff MW.Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase,independent of insulin receptor substrate-I phosphorylation[J]. Diabetes,2003, 52 (10) : 2554-2561.

二级参考文献13

  • 1Hori M, Satoh M, Furukawa K, et al. Acyl-coenzyme A : cholesterol acyl-transferase-2 (ACAT-2)is responsible for elevated intestinal ACAT ac- tivity in diabetic rats [J]. Arterioscler Thromb Vasc Bio1,2004,24(9) : 1689- 1695.
  • 2Duran-Sandoval D, Mautino G, Martin G,et al. Glucose regulates the ex- pression of the famesoid X receptor in liver[J]. Diabetes,2004,53 (4) :890- 898.
  • 3Sakashita N, Miyazaki A, Chang CC, et al. Acyl-coenzyme A : cholesterol acyhransferase2(ACAT2) is induced in monocyte-derived macrophages: in vivo and in vitro studies[J]. Lab Invest, 2003, 83 ( 11 ) : 1569-1581.
  • 4Chang TY, Li BL, Chang CC. Acyl-coenzyme A: cholesterol acyhransfera- ses[J]. Am J Physiol Endocrinol Metab, 2009,297 ( 1 ) : E 1-9.
  • 5Shelness GS, Sellers JA. Very-low-density lipoprotein assembly and sec- retion[J]. Curr Opin Lipidol, 2001,12 (2) : 151-157.
  • 6Lee RG,Shah R,Sawyer JK,et al. ACAT2 contributes cholesteryl esters to newly secreted VLDL whereas LCAT adds CE to LDL in mice[J]. J Lipid Res,2005,46(6) : 1205-1212.
  • 7Hori M ,Satoh M,Furukawa K,et al. Acyl-coenzyme A:cholesterol acyh- ransferase-2 (ACAT-2) is responsible for elevated intestinal ACAT acti- vity in diabetic rats [J]. Arterioscler Thromb Vasc Biol, 2004,24(9) : 1689- 1695.
  • 8Song BL,Qi W,Yang XY,et al. Organization of human ACAT-2 gene and its cell type-specific promoter activity[J]. Biochem Biophy Res Co mmun, 2001,282 (2) : 580-588.
  • 9Song BL,Qi W,Wang CH, et al. Preparation of an anti-Cdx-2 antibody for analysis of different species Cdx-2 binding to acat2 promoter[J]. Acta Bio- chim Biophys Sin, 2003,35 ( 1 ) : 6-12.
  • 10Pramfalk C, Davis MA,Eriksson M, et al. Control of ACAT2 liver expres- sion by HNFI[J]. J Lipid Res ,2005,46(9) : 1868-1876.

共引文献1

同被引文献17

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部